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The vacuolar H
+
-ATPase (V-ATPase) is a 
major contributor to luminal acidification in 
epithelia of Wolffian duct origin. In both 
kidney intercalated cells and epididymal clear 
cells, cAMP induces V-ATPase apical 
membrane accumulation, which is linked to 
proton secretion. We have shown previously 
that the A subunit in the cytoplasmic V1 sector 
of the V-ATPase is phosphorylated by PKA. 
Here we have identified by mass spectrometry 
and mutagenesis that Ser-175 is the major PKA 
phosphorylation site in the A subunit. 
Overexpression in HEK-293T cells of either a 
wild-type (WT) or phospho-mimic Ser-175 to 
Asp (S175D) A subunit mutant caused 
increased acidification of HCO3
-
-containing 
culture media compared to cells expressing 
vector alone or a PKA phosphorylation-
deficient Ser-175 to Ala (S175A) mutant. 
Moreover, localization of the S175A A subunit 
mutant expressed in HEK-293T cells was more 
diffusely cytosolic than that of WT or S175D A 
subunit. Acute V-ATPase-mediated, 
bafilomycin-sensitive H
+
 secretion was up-
regulated by a specific PKA activator in HEK-
293T cells expressing WT A subunit in HCO3
-
-
free buffer. In cells expressing the S175D 
mutant, V-ATPase activity at the membrane 
was constitutively up-regulated and 
unresponsive to PKA activators, while cells 
expressing the S175A mutant had decreased V-
ATPase activity that was unresponsive to PKA 
activation. Finally, Ser-175 was necessary for 
PKA-stimulated apical accumulation of the V-
ATPase in a polarized rabbit cell line of 
collecting duct A-type intercalated cell 
characteristics (Clone C). In summary, these 
results indicate a novel mechanism for the 
regulation of V-ATPase localization and 
activity in kidney cells via direct PKA-
dependent phosphorylation of the A subunit at 
Ser-175. 
 
V-ATPases are ubiquitous and essential 
transport protein complexes that acidify many 
cellular organelles, such as endosomes, lysosomes 
and the Golgi complex (1). The V-ATPase has 14 
subunits distributed into two domains. The V1 
peripheral or cytoplasmic domain, which catalyzes 
ATP hydrolysis, is composed of eight different 
subunits, including subunit A (reviewed in (2)). 
The V0 integral membrane domain, which is 
responsible for H
+
 translocation, consists of six 
different subunits, including subunit a (2). Some 
epithelial cells, such as kidney proximal tubular 
cells, A-type intercalated cells, and epididymal 
clear cells express abundant V-ATPase at their 
apical membrane, where it participates in 
endocytosis and luminal acidification of the 
kidney tubule and the male reproductive tract, two 
epithelia of Wolffian duct origin (3-7). V-ATPase 
dysfunction in kidney cells has been implicated in 
the development of Fanconi syndrome and renal 
tubular acidosis, with severe kidney and 
generalized health sequelae (8-13). In mice, a lack 
of V-ATPase expressing clear cells leads to male 
infertility (14). 
Acid secretion in epithelial cells is actively 
regulated by environmental signals, although the 
mechanisms by which these cues are translated 
into activation of H
+
 transport pathways remains 
the subject of intense research (11,15-19) For 
example, the V-ATPase is regulated by several 
pathways, which involve CO2, 
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phosphatidylinositol 3-kinase, aldolase, 
phosphofructokinase, actin, microtubules, and 
angiotensin in a variety of mammalian cellular 
systems (20-27). The number of V-ATPases at the 
apical membrane of intercalated cells in the kidney 
increases rapidly under conditions of systemic 
acidosis (28,29). Acidosis also induces H
+
 
secretion via the V-ATPase through changes in 
intracellular [Ca
2+
] concentration, calmodulin 
activation, the cytoskeleton, and by altering the 
rate of endocytosis and exocytosis in kidney cells 
(30). 
We and others have shown that regulation of 
the V-ATPase at the apical membrane of 
intercalated and clear cells is tightly linked to 
alkaline luminal pH, HCO3
-
, carbonic anhydrase 
activity, activation of the soluble Adenylyl 
Cyclase (sAC), cAMP, and PKA (19,31-33). In 
cells with abundant carbonic anhydrase, such as 
intercalated cells, increases in extracellular CO2 
during acidosis may result in significant transient 
increases in intracellular [HCO3
-
] and [H
+
]. 
Increased [HCO3
-
] may in turn activate the 
sAC/cAMP/PKA pathway and the V-ATPase at 
the apical membrane of A-intercalated cells 
resulting in enhanced proton extrusion and 
subsequent basolateral recovery of HCO3
-
 into the 
extracellular space (19). 
The role of direct phosphorylation of the V-
ATPase subunits in H
+
 secretion in mammalian 
epithelial cells has not been well characterized 
(19,34,35). Although PKA agonists have been 
shown to regulate the V-ATPase in a variety of 
systems, it was not until recently that the direct 
phosphorylation of V-ATPase subunits by this 
kinase was linked to its regulation. In insect cells 
phosphorylation of the C subunit in the V1 sector 
by PKA contributes to the apical assembly and 
activity of the salivary gland V-ATPase (36,37). 
We have recently shown that the V-ATPase A 
subunit is phosphorylated by PKA in vitro and in 
the intact cellular environment in HEK-293 cells, 
suggesting that direct A subunit phosphorylation 
by PKA could be involved in the trafficking of the 
V-ATPase complex to the apical membrane from 
cytoplasmic pools (19,38,39). 
In this study we have used mass spectrometry 
and phosphorylation assays to identify and 
confirm the main PKA phosphorylation site in the 
V-ATPase A subunit, which is highly conserved 
across species. Moreover, we have established the 
relevance of this residue in the phosphorylation of 
the A subunit in HEK-293 cells that express native 
and active V-ATPase at their plasma membrane 
(40). We have also developed a useful technique 
to monitor V-ATPase activity in live cells and to 
test for the effects of mutations in the pump A 
subunit. Moreover, we have used established 
morphometric methods to confirm that this PKA 
phosphorylation site is required for apical 
accumulation of the pump in response to PKA 
activators in the Clone C cell line, a previously 
characterized rabbit cell line of kidney intercalated 
cell characteristics that expresses V-ATPase. 
 
EXPERIMENTAL PROCEDURES 
 
Reagents and chemicals. All chemicals used in 
the studies presented here were purchased from 
Sigma or Fisher Scientific unless otherwise stated. 
The cell-permeant PKA-specific activator N
6
-
monobutyryl-cAMP (6-MB-cAMP) was obtained 
from Biomol. 
Mass spectrometry of wild-type mouse FLAG-
A V-ATPase subunit. The wild-type (WT) mouse 
FLAG-A subunit construct characterized in our 
previous study (19) was transfected into HEK-
293T cells and immunoprecipitated using the M2 
anti-FLAG monoclonal antibody (Sigma) coupled 
to protein A/G beads (Pierce), as described 
(19,41,42). This FLAG-WT-A V-ATPase subunit 
was phosphorylated by bacterially expressed 
active PKA (43) at 37°C in kinase buffer (10 mM 
HEPES-Cl, pH 7.4, 200 !M ATP, 40 !M AMP, 5 
mM MgCl2) supplemented with [!-
32
P]-ATP for 2 
h. The reaction was stopped by adding SDS-
containing sample buffer and heating to 95°C for 5 
min. The following steps were performed as 
described previously (43) with only one minor 
modification. Briefly, following SDS–
polyacrylamide gel electrophoresis (PAGE) and 
Coomassie-blue staining, the gel band 
corresponding to the FLAG-A V-ATPase subunit 
was excised from the wet gel and subjected to in-
gel digestion with trypsin. Concentrated tryptic 
peptides were applied to a microbore reversed-
phase column connected to a capillary liquid 
chromatography system and equipped with a 
microcollection/spotting system, thus allowing the 
microfractionation onto a Prespotted AnchorChip 
(PAC) (44). After autoradiography, selected 
fractions of the PAC target indicating the presence 
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of radiolabeled phosphopeptides were analyzed by 
matrix-assisted laser desorption ionization mass 
spectrometry (MALDI MS) (44). 
To confirm the phosphorylation site identified 
by mass spectrometry analysis, the candidate 
phosphorylation site was mutated using the 
Stratagene QuikChange kit according to the 
manufacturer’s instructions using as a template the 
pMO-FLAG-A plasmid, which we have used for 
mammalian cell expression (38). All mutations 
were confirmed by DNA sequencing.  
A subunit in vitro phosphorylation assays. In 
vitro phosphorylation assays were performed 
essentially as described previously (38,41). 
Briefly, HEK-293T cells were transiently 
transfected using Lipofectamine 2000 (Invitrogen) 
to express either FLAG-V-ATPase A subunit 
wild-type (FLAG-A-WT, mouse sequence) or this 
subunit with a specific point mutant (Ser-175 to 
Ala; FLAG-A-S175A) identified as the PKA 
target phosphorylation site. Cells were lysed two 
days after transfection, and the FLAG-V-ATPase 
A subunits (WT and S175A) were 
immunoprecipitated from cell lysates using the M2 
anti-FLAG monoclonal antibody (Sigma) coupled 
to protein A/G beads (Pierce). In vitro 
phosphorylation was performed using purified 
active PKA catalytic subunit (Promega) with [!-
32
P]-ATP labeling, as described (38). After SDS-
PAGE and transfer to nitrocellulose membranes, 
immunoblotting for expression of FLAG-V-
ATPase A subunit was first performed and 
quantified using a Versa-Doc Imager with 
Quantity One software (Bio-Rad). After the 
chemiluminescent signal decayed, phosphorylated 
bands on the membrane were identified by 
exposure of the same membrane to a phospho-
screen, and the detected bands were quantitated 
using a Bio-Rad Phosphorimager with Quantity 
One software. The intensity of each phospho-
screen band was corrected by subtracting out the 
local background in the same lane.  
A subunit in vivo phosphorylation assays. 
HEK-293T cells were transiently transfected with 
3 µg of either WT or S175A mutant FLAG-V-
ATPase A subunit plasmid DNA one day before 
experimentation. Phosphorylation assays in HEK-
293T cells were performed essentially as 
previously described (38). In addition, to assess 
potential differences in PKA-mediated [
32
P]-
orthophosphate labeling in the cells across 
conditions, 10 µg of lysate was pre-cleared by 
incubation with protein A/G beads (approximately 
1.5 µL) and then spotted for each condition onto a 
nitrocellulose membrane. The [
32
P]-
orthophosphate-labeled proteins in each spot were 
detected by exposing the membranes to a 
phospho-screen and quantified using a 
phosphorimager. Thereafter, the membranes were 
blocked in 5% BSA in TBST and probed with an 
antibody recognizing a phosphorylated PKA 
consensus epitope (1:15,000; Cell Signaling 
Technologies) to account for potential differences 
in PKA activity modulation across conditions. 
Finally, membranes were stripped and re-probed 
using an anti-"-actin antibody (Sigma) to 
normalize for any differences in total protein 
content in the spotted samples. The total [
32
P]-
orthophosphate and PKA phosphorylated substrate 
signals were corrected for the local background 
signal and normalized to the "-actin immunoblot 
signal in each spot. Each experimental condition 
was repeated three times for each V-ATPase A 
subunit construct. Measurements were analyzed 
and graphed as mean ± SEM. 
Immunofluorescence labeling of HEK-293T 
cells transfected with V-ATPase A subunit 
mutants. HEK-293T cells were seeded onto poly-
L-lysine coated coverslips at 2.5 x 10
5 
cells/cm
2
, 
and transfected with either pMO vector alone or 
pMO-FLAG-A-WT, -FLAG-A-S175A (Ser-175 to 
Ala), or -FLAG-A-S175D (Ser-175 to Asp) A 
subunit using the techniques described above for 
phosphorylation experiments. At least three 
independent coverslips were used in 
immunolabeling experiments for each group of 
transfections (either vector alone, WT, S175A, or 
S175D A subunit). Cells on coverslips were 
incubated for 5 min in concanavalin A coupled to 
CY3 (Vector Laboratories) diluted at 1: 200 for 5 
min in PBS pH 7.4 at 37ºC followed by a brief 
wash in PBS as described (45). All antibodies 
were diluted in DAKO diluent (DAKO 
Laboratories) at various concentrations. The 
coverslips were fixed in 2% paraformaldehyde in 
PBS for 30 min and immunolabeled using an anti-
FLAG antibody raised in mouse (M2 anti-FLAG) 
for 60 min at room temperature (1:50 dilution), 
followed by incubation in secondary goat anti-
mouse antibody coupled to Alexa 488 (1:800 
dilution; Jackson Immunologicals) for 60 min, and 
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then TO-PRO-3 (Invitrogen, 1:400 in PBS) to 
stain the nuclei for 5 min, using our previously 
published protocol in other cell lines (46). Images 
from these coverslips were acquired with identical 
laser confocal microscope settings across all 
transfection conditions. Images were imported into 
Adobe Photoshop for presentation as described 
previously (38). 
Measurement of changes in extracellular 
media pH (pHo). HEK-293T cells were passaged 
every 24-36 h for one week and then seeded onto 
poly-L-lysine-coated 24-well plates at an initial 
concentration of 2.5 x 10
5
 cells/well. The cells 
were transiently transfected the next day with 0.3 
µg/well of plasmid DNA (either vector alone, WT, 
S175A, or S175D; 6 wells per DNA sample). 
Transfected cells were grown in high-glucose, 
bicarbonate-containing DMEM media (Invitrogen) 
supplemented with 10% FBS at 37°C in the 
presence of 5% CO2/95% air. At 28-31 h after 
transfection the medium from each well was 
collected, and its pH was measured using a pH 
meter (Fisher) after careful equilibration of the 
sample with 5% CO2/95% air. Cells were then 
incubated for 5 min at 37°C in 1 mL of a Na
+
-free, 
low buffering capacity solution containing (in 
mM): 135 N-methyl-D-glucamine, 5 KCl, 2 CaCl2, 
1.2 MgSO4, 5.5 D-glucose, 6 L-Alanine, 4 lactic 
acid, 1 HEPES, titrated to pH 7.43 using 1 HCl 
(modified from (47)). The solutions from each 
well were replaced with 1 mL of fresh solution 
and then incubated for 7 min at 37ºC before 
collecting them for pHo measurements, which 
were also performed at 37ºC. This procedure (7-
min incubation followed by pHo measurement) 
was repeated two more times for each well either 
in the presence of vehicle or of 100 !M 6MB-
cAMP / 500 !M IBMX. Reported acidification 
rates (in pH units/min) were calculated from the 
pH drop of the solutions (final minus initial pH) 
over the third 7-min incubation period. After these 
incubations the same procedure was repeated with 
three successive 7-min incubations in the presence 
of 1 µM bafilomycin A1. The V-ATPase-
dependent rate of pHo acidification for each 
sample well was defined as the difference in the 
acidification rate measured in the absence versus 
the presence of bafilomycin A1 (i.e., bafilomycin 
A1-sensitive pH acidification rate). Comparing 
extracellular pH change rates originating from the 
same starting pH in the absence vs. presence of 
bafilomycin allowed us to quantify the V-ATPase-
dependent extracellular acidification rate within 
the same tissue culture well within a short period 
of time. The time frame for action of bafilomycin 
in these cells was ~12-30 min, as evidenced by a 
significant inhibition of extracellular acidification 
starting at ~12 min, and an increase in cell death 
after ~30 min. Thus, by comparing the third of 
three 7-min incubations both in the absence and 
presence bafilomycin, we obtained the 
extracellular acidification rates in the window of 
time where bafilomycin is active against the V-
ATPase but not yet significantly toxic to the cells. 
At the end of each experiment cells were 
collected to determine total cell number, as 
counted with a hemocytometer, and cell viability, 
as assessed by Trypan blue exclusion. We 
prepared at least 12 wells of cells for each plasmid 
type expressed (vector alone, WT, S175A and 
S175D), and half of those wells were treated with 
PKA agonist and the other half with buffer alone. 
To assess FLAG-A subunit expression in the 
transfected cells, we immunoblotted cell lysates at 
the end of the pHo experiments using both anti-
FLAG and anti-"-actin antibodies, as described 
above. In addition, we performed dot blots of these 
cell lysates using the anti-PKA substrate antibody 
to confirm PKA activity changes in these cells 
with the different treatments, as described above.  
Immunofluorescence labeling of V-ATPase 
FLAG-A subunit mutants transiently transfected 
into a cell line of intercalated cell characteristics. 
We used a previously characterized rabbit cell line 
(“Clone C”, a generous gift of Dr. Qais Al-
Awqati), which displays kidney collecting duct 
intercalated cell characteristics (48,49). This cell 
line expresses high levels of functional V-ATPase 
at the apical membrane when cells are seeded at 
high density. Briefly, Clone C cells were grown at 
32ºC in medium containing DMEM/F12 
(Invitrogen), 1.8% heat-inactivated fetal calf 
serum, 27.6 !M hydrocortisone (Sigma), 0.45% 
insulin-transferrin-sodium selenite media 
supplement (Sigma), 15 mg/L epidermal growth 
factor (Sigma), 200 mM glutamine (Sigma), and 
5% penicillin/streptomycin (Invitrogen) as 
previously described (50). Cells were placed into 
serum and antibiotic-free medium for 4 h prior to 
transfection. The cells were then transiently 
transfected according to the manufacturer's 
recommendations using Lipofectamine 2000 with 
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 5 
either FLAG-A-WT or FLAG-A-S175A (3 µg 
plasmid DNA). One day after transfection, cells 
were plated under conditions that confer apical V-
ATPase proton secretion (51) onto 0.33-cm
2
 
Transwell filters (Costar) coated with rat tail 
collagen (BD Biosciences) at a concentration of 5 
x 10
5
 cells per cm
2
 and grown at 40ºC in DMEM 
medium with 1.8% FBS (52).   
Five days after transfection, monolayers on 
filters were incubated in serum-free DMEM for 2 
h and then treated with either vehicle or 1 mM 6-
MB-cAMP and 0.5 mM IBMX for 30 min at 40ºC 
in PBS at pH 7.1. After treatment with agonists, 
cells on filters were incubated in CY3-
concanavalin A (1:100) in PBS at 40ºC. After a 
brief PBS wash, cells were fixed and 
immunolabeled using the M2 anti-FLAG antibody, 
followed by a secondary antibody coupled to 
Alexa-488 (GAM-Alexa 488; 1:50, Invitrogen) 
and the nuclear label TO-PRO-3 using the same 
protocol as described above for HEK-293T cells. 
Filters were imaged from above the first 
appearance of apical fluorescence down to below 
the lowest basolateral fluorescence labeling using 
a Leica confocal microscope. For each set of 
filters the stacks were acquired using identical 
stack dimensions and Z-steps using a 40X 
objective (zoom 3). Transfected cells on the filters 
were selected when they showed both 
concanavalin A and bright anti-FLAG 
immunolabeling by epifluorescence. 
Approximately 30% of the cells in the monolayers 
fulfilled these characteristics. At the time of 
selection of the transfected cells (as determined by 
their bright FITC-associated fluorescence) for 
imaging and acquisition of the stacks, 
investigators were unable to judge the subcellular 
localization of the V-ATPase. Three-dimensional 
reconstructions of confocal stacks were used to 
obtain X-Z or X-Y projections of the transfected 
cells in the monolayers, which were then imported 
into Metamorph for quantification. V-ATPase 
apical accumulation was determined by measuring 
the mean pixel intensity (MPI) of FLAG-
associated fluorescence in an apical ROI (ROI-1, 
co-localizing with CY3-concanavalin A) and a 
cytoplasmic ROI of identical size immediately 
below concanavalin A labeling (ROI-2), using a 
very similar procedure to ones previously 
described by us (19,38,53). The brightest area of 
the cell at the apical membrane was chosen for 
measuring the ROI-1 (approximately, 200 pixels). 
After X-Z reconstruction, at least two additional 
investigators blinded as to the nature of the 
transfected subunits evaluated the distribution of 
anti-FLAG labeling in TIF images of these cells. 
The degree of apical accumulation of the V-
ATPase FLAG A subunit mutants was determined 
by the ratio of apical-to-cytoplasmic ROI (ROI-
1/ROI-2) of FLAG-associated fluorescence for 
each cell. At least five separate Clone C filters 
were evaluated for each of four conditions: FLAG-
A-WT  incubated in PBS pH 7.1 ± 6-MB-cAMP / 
IBMX and  FLAG-A-S175A incubated in PBS pH 
7.1 ± 6-MB-cAMP / IBMX. For each of these four 
studied conditions in Clone C monolayers, we 
quantified 20-45 cells.  
Co-immunoprecipitation studies. Clone C cells 
were transfected with FLAG-WT A subunit 
plasmid as described above. One day after 
transfection, cells were harvested in ice-cold lysis 
buffer using our established techniques (41). We 
used 1 mg of pre-cleared lysate for 
immunoprecipitations performed at 4°C on each 
sample using the M2 anti-FLAG antibody (0.5 
µg/immunoprecipitation) coupled to protein A/G 
beads. As a control, immunoprecipitation in the 
absence of the anti-FLAG antibody was also 
performed. After three washes in lysis buffer, the 
immunoprecipitation samples were eluted in 
sample buffer and, along with the cell lysate 
samples, subjected to SDS-PAGE. 
Immunoblotting was performed with either: 1) V0 
a subunit antibody (1:2,000 dilution, raised in 
rabbit, Santa Cruz), 2) V1 A subunit antibody 
(1:5,000 dilution, raised in chicken, Sigma) or 3) 
V1 E subunit antibody (1:10,000 dilution, raised in 
chicken, Sigma), followed by the appropriate 
secondary antibodies coupled to HRP (Jackson 
Immunologicals) (38). 
Statistics. Data shown represent means ± SEM 
for each group. Significance was determined using 
two-tailed, unpaired Student’s t-tests assuming 
unequal variances between the treatment groups. P 
values <0.05 were considered significant. 
 
RESULTS 
 
PKA phosphorylates the V-ATPase A subunit 
at Ser-175. We have previously shown that the V-
ATPase A subunit can be phosphorylated both in 
vitro and in vivo by AMPK and PKA when 
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 6 
heterologously expressed in HEK-293 kidney cells 
(38). However, actual PKA phosphorylation sites 
within the A subunit have not yet been identified. 
Using a novel approach involving a liquid 
chromatography matrix-assisted laser 
desorption/ionization mass spectrometry (LC–
MALDI MS) workflow, we were able to localize 
and quantify phosphorylated peptides on a 
MALDI target plate prior to MS analysis (43). 
Using this technique with in vitro PKA-
phosphorylated V-ATPase FLAG-tagged A-WT 
subunit, we identified a major phospho-labeled 
tryptic peptide fragment that eluted in fraction 
O21 (Figs. 1A and 1B). In this elution peak we 
detected a phosphorylated peptide corresponding 
to the expected molecular mass of a tryptic 
fragment with sequence 
NRGSVTYIAPPGNYDASDVVLELEFEGVK, 
for which sequence confirmation was obtained by 
fragmentation using MS/MS (see Supplemental 
Data, Fig. S1). This peptide fragment (underlined 
in Fig. 1C) contains two serines, however only 
Ser-175 (bolded in Fig. 1C) fits within a consensus 
PKA phosphorylation site. The amino acid 
sequence around this residue is highly conserved 
in vertebrates (Fig. 1D), suggesting that PKA 
phosphorylation at this site could play a 
fundamental role in V-ATPase function. 
To further confirm that Ser-175 is a specific 
PKA phosphorylation site in vitro, we generated a 
putative phosphorylation-deficient FLAG-tagged 
A-subunit mutant with Ser-175 mutated to Ala 
(S175A) and then performed in vitro 
phosphorylation experiments, using methods 
previously described (38). We then compared in 
vitro phosphate labeling of WT vs. the S175A V-
ATPase A subunits exposed to purified active 
PKA catalytic subunit in the presence of [!-
32
P]-
ATP (Figs. 2A and 2B). The S175A V-ATPase A 
subunit mutant had a >90% reduction in 
32
P 
labeling relative to WT A subunit after 
normalization to the amount of 
immunoprecipitated protein, confirming PKA-
dependent phosphorylation at this residue in vitro. 
Together, the mass spectrometry analysis and in 
vitro phosphorylation results reveal that PKA 
phosphorylates the V-ATPase subunit at this 
highly conserved site in mammalian and other 
vertebrate animals. 
PKA-dependent in vivo phosphorylation of the 
V-ATPase A subunit in HEK-293T cells occurs at 
Ser-175. To determine whether Ser-175 is a target 
for PKA-dependent phosphorylation in intact 
HEK-293T cells, we compared [
32
P]-
orthophosphate labeling of the FLAG-A-WT and 
FLAG-A-S175A mutant subunits under control 
conditions or following treatment with PKA 
activators (100 !M 6-MB-cAMP + 500 !M 
IBMX) or a specific PKA inhibitor (10 !M mPKI) 
(Fig. 3A). The phosphate-labeling signal on the 
phospho-screen (upper panel) was normalized to 
the respective FLAG-A subunit expression signal 
on the immunoblot (lower panel) from the same 
membrane. 
Stimulation of cellular PKA activity by PKA 
activators significantly increased phosphorylation 
of the FLAG-A-WT subunit to ~3.5 times that of 
control-treated cells (Fig. 3B, lanes 1 and 2). 
Treatment with the PKA inhibitor mPKI did not 
significantly decrease the level of WT A-subunit 
phosphorylation compared with untreated cells, 
although there was an inhibitory trend with mPKI 
treatment (Fig. 3B, lanes 1 and 3). The changes in 
WT and mutant A subunit phosphorylation with 
PKA modulation were qualitatively similar to the 
changes in overall cellular PKA-phosphorylated 
substrates, as measured by a dot blot detecting 
PKA-phosphorylated proteins in the total cellular 
lysate (compare Fig. 3B, lanes 1-3, with Fig. 3D, 
lanes 1-3). These results are consistent with our 
earlier published results on WT A subunit 
phosphorylation by PKA in cells (38). 
Untreated cells expressing the S175A A 
subunit mutant had ~50% lower phosphorylation 
levels compared with untreated cells expressing 
the WT A subunit (Figs. 3A and 3B, lanes 1 and 
4). This result indicates that Ser-175 in the A 
subunit is likely a target of baseline 
phosphorylation in unstimulated cells. Moreover, 
the robust enhancement in phosphorylation of the 
FLAG-A-WT subunit following PKA stimulation 
was completely blocked in the FLAG-A-S175A 
mutant subunit (compare Figs. 3A and 3B, lanes 1 
and 2 with lanes 4 and 5). This blockade could not 
be attributed to a lack of PKA activation in the 
S175A mutant subunit-expressing cells, as total 
cellular PKA-phosphorylated substrates 
approximately doubled with PKA stimulation in 
both WT- and mutant A subunit-expressing cells 
(Fig. 3D, lanes 2 and 5). Together, these results 
strongly indicate that Ser-175 in the V-ATPase A 
subunit is the main target of PKA phosphorylation 
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 7 
in vivo (i.e., in an intact cellular environment). 
Ser-175 is required for V-ATPase subcellular 
localization and activity in HEK-293T cells. HEK-
293 cells express the V-ATPase at their plasma 
membrane, where it has been shown to extrude 
protons (40). Lang et al. demonstrated that other 
H
+
-secreting transporters, such as Na
+
/H
+
 
exchangers (NHEs), are not active in HEK-293 
cells with neutral to alkaline intracellular pH (40). 
To examine the subcellular localization of the V-
ATPase A subunit expressed in HEK-293T cells, a 
commercially-available subclone of HEK-293 
cells (45), we transfected these cells with either 
FLAG-tagged WT or mutant A subunits. We then 
performed immunofluorescence labeling of the A 
subunit immediately after removing the cells from 
culture medium using an anti-FLAG antibody 
followed by confocal fluorescence microscopy 
(Fig. 4, A-D). Cells transfected with either FLAG-
A-WT or with FLAG-A-S175D exhibited 
immunolabeling largely at or near the plasma 
membrane (co-labeled with concanavalin A-CY3, 
in red), with less prominent cytosolic staining 
(Fig. 4, B and D). However, HEK-293T cells 
transfected with FLAG-A-S175A displayed a 
more predominant cytosolic distribution than 
HEK-293T cells expressing WT or S175D A 
subunits (Fig. 4C). Immunolabeled cells that were 
transfected with vector alone showed very little 
non-specific staining (Fig. 4A). All confocal 
images shown were acquired using identical laser 
settings in cells that immunolabeled on the same 
day under the same conditions. Together, these 
results suggest that phosphorylation at Ser-175 in 
the A subunit may play a functional role in the 
subcellular distribution of the V-ATPase in these 
cells. 
To more directly assess the role of A subunit 
residue Ser-175 in the activity of the V-ATPase at 
the plasma membrane, we transfected HEK-293T 
cells with either vector alone, WT, or mutant A 
subunits (S175A or S175D), incubated in the same 
volume of culture medium and then measured the 
extracellular pH (pHo) of the medium 28-31 h after 
transfection (Fig. 4E). Fresh HEK-293T cell 
culture medium had a measured pH of 7.48 ± 0.01 
at 37°C in a 5% CO2 environment. In cells 
transfected with either vector alone or the PKA 
phosphorylation-deficient S175A A-subunit 
mutant, only modest acidification of the media 
occurred over the subsequent 28-31 h (to a pHo of 
7.33-7.35; Fig. 4E, lanes 1 and 3). Expression of 
the WT A subunit significantly enhanced 
acidification of the medium relative to vector 
alone (to a pHo of 7.17 ± 0.02; Fig. 4E, lane 2). 
Finally, expression of the phospho-mimic S175D 
A-subunit mutant caused an even more profound 
and significant acidification of the culture medium 
(to a pHo of 7.03 ± 0.02; Fig. 4E, lane 4). Thus, the 
degree of media acidification observed after 
transfection of WT and Ser-175 mutant A subunits 
into HEK-293 cells (Fig. 4E) were consistent with 
qualitative changes in expression of the transfected 
subunits at or near the plasma membrane (Figs. 
4A-4D). The total cell number, as counted on a 
hemocytometer at the end of each experiment, and 
viability, as measured by Trypan blue exclusion, 
did not differ significantly across transfection 
conditions (between 0.99 x 10
6
 and 1.10 x 10
6
 
cells per well and between 94.1 and 95.6% cell 
viability across all transfection conditions). 
Moreover, nuclear staining did not reveal blebbing 
of cell nuclei under any of the conditions tested 
(Figs. 4A-4D), which suggests that apoptosis was 
not occurring to a significant extent (54). 
Expression levels of FLAG-tagged A subunits in 
transfected cells were quite comparable, as 
demonstrated in the immunoblots of the 
phosphorylation experiments in intact HEK-293T 
cells (Fig. 3). These considerations suggest that 
changes in media pH in cultures were not due to 
differences in cell death, growth rates, transfected 
subunit expression levels, or plating across 
conditions. 
In additional experiments we monitored pHo 
changes under acute conditions (over 7-min 
intervals) in HEK-293T cells seeded at equal 
densities into 24-well plates and transfected with 
either vector alone or plasmid to express WT, 
S175A or S175D mutant A subunit (Fig. 5). V-
ATPase-dependent acidification was measured as 
described in Experimental Procedures after 
replacing the culture medium with a low buffering 
capacity solution. This buffer was prepared 
without Na
+
 to minimize any contribution of 
Na
+
/H
+
 exchange to pHo and in the nominal 
absence of HCO3
- 
to minimize sAC activity, which 
could independently increase intracellular [cAMP] 
and PKA activity (31,40,55). We confirmed that 
HEK-293T cells incubated in this weakly buffered 
solution express sufficient V-ATPase at their 
plasma membrane to generate significant changes 
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 8 
in pHo. When comparing untreated (Fig. 5A) vs. 6-
MB-cAMP-treated cells (Fig. 5B), only over-
expression of the WT A subunit caused a 
significant change in the V-ATPase-dependent 
acidification rate (expressed as [-(final buffer pH - 
initial buffer pH)/#t]). Specifically, expression of 
vector alone and S175A maintained relatively low 
acidification rates, and S175D maintained a high 
acidification rate under both untreated and PKA-
stimulated conditions. On the other hand, the WT 
A subunit had a low acidification rate under 
untreated conditions that converted to a high 
acidification rate in the presence of the PKA 
activators 6-MB-cAMP and IBMX. Comparing 
the different transfection conditions in cells 
incubated with buffer alone (untreated), only 
vector alone and S175A had V-ATPase-dependent 
acidification rates that were not statistically 
different from one another. The relative measured 
acidification rates were: vector ~ S175A < WT < 
S175D (Fig. 5A). Comparing the different 
transfection conditions in the presence of the PKA 
activators, both vector alone vs. S175A and WT 
vs. S175D had V-ATPase-dependent acidification 
rates that were not statistically different from one 
another. The relative measured acidification rates 
with PKA stimulation were: vector ~ S175A < WT 
~ S175D (Fig. 5B). Of note, as observed in Fig. 3, 
during the time frame of these pHo measurements, 
there was comparable expression of each FLAG-A 
subunit, and the level of total PKA-phosphorylated 
substrate in cells significantly increased with 6-
MB-cAMP and IBMX treatment (data not shown). 
Taken together, the results presented so far suggest 
that PKA-mediated phosphorylation of the A 
subunit at Ser-175 in HEK-293T cells may be both 
necessary and sufficient to confer V-ATPase 
activity at the plasma membrane under conditions 
that minimize intracellular HCO3
-
 and the 
contribution to H
+
 secretion by NHEs. In the 
presence of bafilomycin and in the absence of Na
+
, 
we still observed a slight but consistent drop in 
pHo (Fig. S2) which could be due to other Na
+
-
independent, H
+
-extruding transporters, such as 
the H
+
-monocarboxylate co-transporters of the 
SLC16 family, which are known to be expressed 
in the HEK-293 cell line (56,57). 
Ser-175 is required for PKA-mediated V-
ATPase A-subunit apical accumulation in Clone C 
intercalated cells. To evaluate the role of PKA-
dependent phosphorylation at Ser-175 in the A 
subunit vis-à-vis subcellular localization changes 
of the V-ATPase in a more physiologically 
relevant cell system, we expressed the FLAG-A 
subunit in a rabbit cell line of intercalated cell 
characteristics, Clone C. This cell line has been 
previously characterized and, when plated at high 
density, expresses active V-ATPase at the apical 
membrane (49). First, we performed co-
immunoprecipitation experiments to determine 
whether the exogenously expressed FLAG-A-WT 
subunit incorporates into endogenous V-ATPase 
complexes. As demonstrated by immunoblotting 
with specific antibodies that recognize endogenous 
V-ATPase subunits, we confirmed that both the V-
ATPase a subunit of the membrane-embedded Vo 
sector (Fig. 6A, upper panels) and the E subunit of 
the V1 sector (Fig. 6A, lower panels) co-
immunoprecipitated with transfected FLAG-A-
WT subunit expressed in Clone C cells (Fig. 6A, 
middle panel). 
Next, we performed immunofluorescence 
labeling of V-ATPase FLAG-A-WT or S175A 
mutant subunit expressed in polarized Clone C 
cells followed by confocal microscopy. The 
FLAG-A-WT subunit was distributed in both 
apical and cytosolic domains when expressed in 
Clone C cells and incubated in PBS at pH 7.1 (Fig. 
6B, left upper panel). Under this incubation 
condition we minimized any exposure of the cells 
to hormones and agonists present in serum (by 
serum starving the monolayers for 2 h), which 
could potentially influence intracellular 
cAMP/PKA. The use of PBS pH 7.1 during the 
incubation also minimized HCO3
-
-induced 
trafficking of the V-ATPase in proton-secreting 
cells as previously described (31). When Clone C 
cells expressing the FLAG-A-WT subunit were 
treated with the PKA activators 6-MB-cAMP and 
IBMX, these cells accumulated FLAG-associated 
fluorescence at their apical poles (Fig. 6B, upper 
right panel). In contrast, the FLAG-A-S175A 
mutant subunit showed a more diffuse cytoplasmic 
distribution both in the presence and absence of 
PKA agonists (Fig. 6B, lower panels). 
Quantification of the apical-to-cytoplasmic 
MPI of FLAG-associated fluorescence in Clone C 
cells transfected with WT vs. S175A A subunit 
confirmed a significantly lower apical 
accumulation of the S175A A-subunit mutant (Fig. 
6C), and its unresponsiveness to trafficking to the 
apical membrane by PKA agonists. Our 
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quantification also reveals that transfected FLAG-
A-WT subunit in Clone C cells traffics to the 
apical membrane in the same 30-min time frame 
that the E subunit accumulates at the apical 
membrane of intercalated cells in kidney tissue 
slices in response to 6-MB-cAMP (19,39). In 
summary, these results suggest that 
phosphorylation at Ser-175 is required for the 
PKA-mediated apical accumulation in polarized 
kidney intercalated cells. 
 
DISCUSSION 
 
An area of particular research interest in 
kidney and epithelial cell physiology is in the 
understanding of how changes in intracellular and 
extracellular pH are sensed acutely by proton-
secreting cells and translated into the activation of 
transporters such as the V-ATPase (17,32). It has 
been shown that V-ATPase subcellular 
localization and/or V-ATPase-dependent proton 
secretion are regulated by a variety of stimuli, 
including changes in intracellular and extracellular 
pH, extracellular [CO2], intracellular [Ca
2+
], and 
[HCO3
-
] in proton-secreting cells derived 
embryologically from the Wolffian duct 
(20,51,58,59). Carbonic anhydrase and sAC are 
very abundant in kidney intercalated cells, where 
sAC activation generates cAMP upon increases of 
CO2 that may occur under conditions of acute 
respiratory acidosis (31,60). We envision that in 
response to an acute intracellular increase of 
[CO2], HCO3
-
 production catalyzed by carbonic 
anhydrase in the intercalated cell (11,58) would 
generate cAMP via sAC and thereby induce acute 
PKA-dependent trafficking of the V-ATPase to the 
apical membrane for rapid proton secretion (19). 
To date, the mechanisms of kinase-dependent 
regulation of V-ATPase trafficking in mammalian 
cells have been unknown (34,38,61). Our previous 
work demonstrated that direct phosphorylation of 
the V-ATPase A subunit occurred in HEK-293 
cells, and we proposed that such phosphorylation 
could potentially play an important role in the 
regulation of subcellular localization and activity 
of the V-ATPase in kidney intercalated cells 
(19,38,39). This mode of regulation of V-ATPase 
activity could also prove to be relevant in the 
proximal tubule of the kidney to the extent that 
PKA or other relevant kinases may become 
activated there. However, the levels of sAC in the 
epithelium of that nephron segment are lower than 
in the collecting duct (31). These findings may 
also be relevant to trafficking of the V-ATPase in 
other epithelia such as epididymal clear cells, 
where the V-ATPase accumulates at the apical 
membrane in response to PKA (61). 
In this study we have identified Ser-175 as the 
dominant PKA site in the V-ATPase A subunit by 
two complementary approaches, mass 
spectrometry and candidate site mutagenesis with 
subsequent in vitro and in vivo phosphorylation 
studies performed in HEK-293T cells (Figs. 1-3). 
Immunolocalization studies performed in HEK-
293T cells indicated that in the presence of HCO3
-
-
containing medium, the WT and S175D mutants 
accumulated in sub-membrane regions, a finding 
that mirrored acidification of the culture medium 
under those transfection conditions (Fig. 4). 
Furthermore, in the nominal absence of 
extracellular bicarbonate and Na
+
, the proton-
secreting activity of HEK-293T cells transfected 
with the A subunit was largely bafilomycin-
sensitive and thus V-ATPase-dependent (Fig. 5). 
Moreover, under these conditions cells transfected 
with the WT A subunit responded to PKA 
activation, whereas PKA phosphorylation-
deficient and phospho-mimic Ser-175 mutants 
were unresponsive to PKA, having either 
constitutively reduced or elevated V-ATPase 
activity at the plasma membrane, respectively. 
PKA-mediated phosphorylation of the A subunit at 
Ser-175 thus appears to be both necessary and 
sufficient to confer V-ATPase activity at the 
plasma membrane in HEK-293 cells. Finally, the 
immunolocalization studies performed in Clone C 
cells expressing either WT or S175A mutant A 
subunit suggest that phosphorylation at Ser-175 is 
also required for the apical membrane 
accumulation of the V-ATPase following 
treatment with PKA activators in a relevant 
polarized epithelial cell line of intercalated cell 
characteristics (Fig. 6).  
The finding that over-expression of the WT A 
subunit significantly enhanced V-ATPase-
dependent extracellular acidification (Fig. 5) 
suggests that abundance of the A subunit of the V-
ATPase may be rate-limiting for the formation of 
active V-ATPase holoenzyme complex at the 
plasma membrane in HEK-293T cells. Of note, the 
kinetics of assembly of the V-ATPase have largely 
been investigated in the yeast system (reviewed in 
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(62)). It has been described that the A subunit of 
the V1 sector associates at a faster rate with the V0 
sector a subunit than with other subunits of the V1 
sector (reviewed in (1)). 
Additional studies are needed to better define 
the molecular mechanism(s) by which PKA-
dependent phosphorylation at Ser-175 in the A 
subunit is associated with increased plasma 
membrane accumulation and activity of the V-
ATPase. Specifically, it is conceivable that PKA 
phosphorylation of the A subunit modulates 
protein-protein interactions within the multi-
subunit V-ATPase complex and/or with other 
interacting proteins involved with cellular 
trafficking of the pump. For example, the 
sequence around our identified PKA 
phosphorylation site is highly conserved in 
eukaryotes and lies within a so-called ‘non-
homologous’ region (63). This region received its 
name because it is not present in the F-ATPase " 
subunit, which otherwise has high homology to the 
V-ATPase A subunit. It has been described that 
the highly conserved non-homologous region in 
the A subunit of the V1 sector binds to the V0 
sector in a glucose-dependent manner in yeast, 
where it has been proposed to be a glucose sensor, 
thereby linking pump function to metabolic status 
(2,64). 
To our knowledge, this study is the first to 
identify and characterize the functional role of a 
specific phosphorylation site of any V-ATPase 
subunit in mammalian cells. Our previous work 
demonstrated that in addition to PKA, the 
metabolic-sensing kinase AMPK can directly 
phosphorylate the A subunit of the V-ATPase 
(38). An antagonistic regulatory relationship 
between PKA and AMPK with respect to 
subcellular localization of the pump in both 
epididymal clear cells and kidney intercalated cells 
was also suggested (19). Specifically, AMPK 
appeared to inhibit PKA-dependent 
phosphorylation of the A subunit in cells and 
blocked the PKA-mediated accumulation of the 
pump at the apical membrane in proton-secreting 
cells in kidney and epididymis. However, the 
mechanistic details of how V-ATPase 
phosphorylation by these two kinases may be 
translated into an integrated response of the pump 
to disparate cellular signals is unclear. 
Specifically, it will be important in future studies 
to define how PKA-dependent phosphorylation of 
the pump may couple the sensing of acid-base 
status to pump activity while AMPK-dependent 
phosphorylation of the V-ATPase may couple its 
activity to metabolic and other cellular stresses.
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1
The abbreviations used are: 6-MB-cAMP, N
6
-monobutyryl-cAMP; AMPK, AMP-activated protein 
kinase; BSA, bovine serum albumin; DMEM, Dulbecco’s modified Eagle’s medium; HEK, human 
embryonic kidney; LC–MALDI MS, liquid chromatography matrix-assisted laser desorption/ionization 
mass spectrometry; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate, IBMX, 3-isobutyl-1-
methylxanthine; mPKI, myristoylated protein kinase A inhibitor; NHE, Na
+
/H
+
 exchanger; PAC, 
prespotted AnchorChip; pHo, Extracellular pH, PKA, protein kinase A; ROI, region of interest; S175A, 
Serine -175 to Alanine; S175D, Serine-175 to Aspartic Acid; sAC, soluble adenylyl cyclase; SEM, 
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standard error of the mean; TBST, Tris buffered saline-Tween; V-ATPase, Vacuolar H
+
-ATPase; WT, 
wild-type. 
 
FIGURE LEGENDS 
 
Figure 1. Identification of Ser-175 as a major site for PKA phosphorylation in the V-ATPase A 
subunit. FLAG-A V-ATPase subunit expressed in HEK-293T cells was incubated with a 
substoichiometric amount of PKA in the presence of [!-
32
P]-ATP, the proteins were subjected to SDS-
PAGE and the band corresponding to FLAG-A V-ATPase A-subunit was excised. A. Autoradiographic 
film showing the fractionation profile of phosphopeptide mixtures after in-gel-digestion and 
microfractionation onto PACs. B. Analysis by densitometry of individual radioactive spots identified after 
the microfractionation (shown in A) and quantification of the phosphorylated peptides using appropriate 
standards. The major radioactive peak eluted in fraction E10 and the corresponding phosphorylated 
peptide was identified by mass spectrometry. C. Mouse FLAG-tagged V-ATPase A subunit amino acid 
sequence highlighting the major peptide phosphorylated by PKA (O21 fraction). D. Ser-175 (bold) is part 
of a highly conserved PKA consensus target phosphorylation site in this peptide.  
 
Figure 2. PKA phosphorylation of the A subunit in vitro occurs at Ser-175. A. Typical phospho-
screen image (upper) revealing the signal of PKA in vitro phosphorylated A subunit compared to the Ser-
175 to Ala mutant. The immunoblot blot (lower) confirms similar protein expression and loading of the 
gel for the different conditions. B. Quantification of mean (± SEM) V-ATPase A subunit phosphorylation 
signal normalized for protein loading as assessed by densitometry of Western blot. Compared to wild-
type (WT) FLAG-A subunit, the phosphorylation-deficient (Ser to Ala) mutant showed a significant 90-
95% decrease in phosphorylation by PKA in vitro (*, p < 0.05 relative to WT; n = 3).  
 
Figure 3. PKA-dependent in vivo phosphorylation of the V-ATPase A subunit in HEK-293T cells 
occurs at Ser-175. FLAG-tagged WT or S175A mutant A subunit was transfected into HEK-293T cells 
one day before experimentation, and cells were then incubated with [
32
P]-orthophosphate for 2 h under 
control conditions or in the presence of PKA activator (1 mM 6-MB-cAMP; last 20 min of labeling 
period) or PKA inhibitor (10 !M mPKI; for entire labeling period). Cell lysis, immunoprecipitation using 
an anti-FLAG antibody, SDS-PAGE, immunoblotting using an anti-FLAG antibody, and exposure of the 
same membrane to a phospho-screen were then performed as described (38). A. Typical phospho-screen 
image (upper panel) revealing the signal of phosphorylated A subunit in cells expressing FLAG-A-WT 
subunit (lanes 1-3) or FLAG-A-S175A subunit (lanes 4-6). Lanes 1 and 4 were derived from control-
treated cells, lanes 2 and 5 were derived from PKA-stimulated cells, and lanes 3 and 6 were derived from 
PKA-inhibited cells. The Western blot (lower panel) confirms similar protein expression and loading of 
the gel for the different conditions. B. Quantification of mean (± SEM) V-ATPase A subunit 
phosphorylation signal relative to FLAG-A-WT control condition and normalized for protein expression. 
PKA activator increased FLAG-A-WT phosphorylation to ~3.5 times that of the control condition, 
whereas FLAG-A-S175A mutant subunit phosphorylation was reduced across all conditions to ~0.5 times 
that of the FLAG-A-WT subunit under the control condition (*, p < 0.05 relative to WT control by 
analysis of variance; n = 3 replicate experiments). C. Dot blots using the PKA phosphorylation substrate-
specific antibody of whole cell lysate samples taken from cells transfected and treated under the same 
conditions as shown in A and B and spotted onto a nitrocellulose filter. D. Quantification of mean (± 
SEM) PKA-phosphorylated substrate signal relative to that FLAG-A-WT-transfected cell lysates under 
the control condition and normalized to "-actin blot signal re-probed on the same dot blot (not shown). 
PKA activator 6-MB-cAMP increased PKA-phosphorylated substrate signal to 2-2.5 times that of control 
(*p < 0.05, relative to FLAG-A-WT control; unpaired t-tests), whereas mPKI had no significant effect. As 
a further control, we measured the levels of [
32
P]orthophosphate protein labeling in cellular lysates. We 
did not observe any statistically significant difference across conditions, independently of the A-subunit 
mutant expressed and of the pharmacologic treatments (n = 3 per condition; data not shown). 
A. Immunofluorescence labeling of V-ATPase in collecting duct kidney slices 
treated with different agents for 75 min in Ringer’s buffer. Myristoylated 
protein kinase inhibitor (mPKI) prevented V-ATPase apical accumulation 
compared to ICs in sl ices incubated in Ringer’s buffer. Regions of interest (ROI) 
were outl ined for each cell at apical and subapical regions as in Fig. 2. (Green :  
V-ATPase E subunit). 
B. Quantification of V-ATPase apical accumulation. These data summarize at 
least three separate experiments of the condit ions in Panel A quantifying a total 
of at least 30 cells (*, p < 0.05 respect to control).  
C. Immunofluorescence labeling of V-ATPase in collecting duct  kidney slices 
treated under different conditions for 30 min in Ringer’s buffer. During 
shorter incubations in Ringer’s buffer the V-ATPase had a diffuse cellular 
distr ibution in ICs. cAMP induced apical accumulation of the V-ATPase. 
D. Quantification of V-ATPase apical accumulation (Condit ions in Panel C). 
A. Immunofluorescence labeling of V-ATPase in collecting duct kidney slices 
treated with different agents f r 75 min in Ringer’s buffer. o Myristoylated 
protein kinase inhibitor (mPKI) prevented V-ATPase apical accumulation 
co pared t  ICs i  sl ices incubated in Ring r’s buffer. Re ions of inter st (ROI) o n e g e
w re outl i ed for each cell at ae n pical and subapical regions as in Fig. 2. (Green :  
V-ATPase E subu it).n  
B. Quantification of V-ATPase apical accumulation. These data summarize at 
least three separate experiments of the condit ions in Panel A quantifying a total 
of at least 30 cells (*, p < 0.05 respect to control).  
C. Immunofluorescence labeling of V-ATPase in collecting duct  kidney slices 
treated under different conditions for 30 min in Ringer’s buffer. During 
shorter incubations in Ringer’s buffer the V-ATPase had a diffuse cellular 
distr ibution in ICs. cAMP induced apical accumulation of the V-ATPase. 
D. Quantification of V-ATPase apical accumulation (Condit ions in Panel C). 
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Figure 4. Expression of WT and mutant V-ATPase A subunit in HEK-293T cells modulates 
subcellular localization of the A subunit and extracellular pH. HEK-293 cells were transfected with 
either vector alone (A) or FLAG-tagged WT (B), S175A (C), or S175D (D) mutant A subunit one day 
prior to immunofluorescence staining for expression of FLAG (green), concanavalin A coupled to CY3 as 
a membrane marker (red), and TO-PRO-3 nuclear stain (blue). Scale bar = 15!m. E. Extracellular pH 
(pHo) of the culture media from HEK-293T cells transfected with different plasmids after 28-31 h 
incubation (*, p < 0.0001 relative to vector alone; #, p < 0.0001 relative to WT; n = 15-18). 
 
Figure 5. Bafilomycin-sensitive, V-ATPase-dependent extracellular acidification is modulated by 
Ser-175 A subunit mutants and PKA activators in HEK-293T cells. Cells were transfected with vector 
alone, WT, S175A or S715D mutant FLAG-tagged A subunit for 28-31 h, and the rate of extracellular 
acidification in each set of transfected cells was measured in a low buffering capacity solution before and 
after the addition of bafilomycin A1, a specific V-ATPase inhibitor (see Experimental Procedures). The 
rate of extracellular acidification (-[final buffer pH - initial buffer pH]/#t) was obtained in the absence or 
presence of bafilomycin, for cells incubated either with (A) or without (B) PKA activators (n = 6 for each 
transfection condition; n = 6 for each treatment condition) (*, p < 0.005 relative to vector alone; #, p < 
0.02 relative to WT). 
 
Figure 6. The phosphorylation-deficient V-ATPase A subunit Ser-175 to Ala mutant does not 
accumulate at the apical membrane of intercalated cells in response to PKA activators. The Clone C 
cell line of intercalated cell characteristics was used for independent transient transfections using either 
WT or S175A A subunit. A. Immunoprecipitation using an anti-FLAG antibody (IP-FLAG; left column) 
followed by immunoblotting using antibodies against the a (upper), A (middle), or E (lower) V-ATPase 
subunits revealed that the transfected FLAG-tagged A subunit forms a complex with the native V0 sector 
a subunit and with the V1 sector E subunit. No co-immunoprecipitation was observed when no antibody 
was added to the immunoprcipitation reaction (center column). Samples of the whole cell lysate (5%) 
were also directly immunoblotted for each of the three subunits (right column). B. One day after 
transfection with either FLAG-A wild-type subunit (top panels) or FLAG-A S175A mutant subunit 
(lower panels), Clone C cells were plated onto Transwell filters. After 4 d the filters were incubated in 
PBS pH 7.1 with 100 !M 6-MB-cAMP and 0.5 mM IBMX (right panels) or with PBS pH 7.1 alone (left 
panels) for 30 min. These incubations were followed by an incubation with concanavalin A coupled to 
CY3 (red) for 5 min in PBS pH 7.1, fixation and immunofluorescence labeling using anti-FLAG antibody 
(green) and TO-PRO-3 nuclear stain (blue). Scale bar = 10 !M. C. Quantification of V-ATPase-
associated MPI ratio of apical ROI-1 (where the A-subunit co-localizes with concanavalin A) and 
cytoplasmic ROI-2 (A-subunit alone). This ROI-1/ROI-2 ratio under the different conditions reveals a 
significant PKA-mediated apical V-ATPase accumulation in the cells expressing the WT A subunit 
compared to cells expressing the S175A mutant (ROI-1/ROI-2 ratio presented as mean (± SEM); *, p < 
0.05 versus V-ATPase A WT; n = 20-45 cells analyzed for both conditions).  
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Amino Acid Sequence N-term FLAG TAG V-ATPase A subunit (625aa)
MDYKDDDDKDFSKLPKIRDEDKESTFGYVHGVSGPVVTACDMAGAAMYELVRVGH
SELVGEIIRLEGDMATIQVYEETSGVSVGDPVLRTGKPLSVELGPGIMGAIFDGI
QRPLSDISSQTQSIYIPRGVNVSALSRDIKWEFIPSKNLRVGSHITGGDIYGIVN
ENSLIKHKIMLPPRNRGSVTYIAPPGNYDASDVVLELEFEGVKEKFSMVQVWPVR
QVRPVTEKLPANHPLLTGQRVLDALFPCVQGGTTAIPGAFGCGKTVISQSLSKYS
NSDVIIYVGCGERGNEMSEVLRDFPELTMEVDGKVESIMKRTALVANTSNMPVAA
REASIYTGITLSEYFRDMGYHVSMMADSTSRWAEALREISGRLAEMPADSGYPAY
LGARLASFYERAGRVKCLGNPEREGSVSIVGAVSPPGGDFSDPVTSATLGIVQVF
WGLDKKLAQRKHFPSVNWLISYSKYMRALDEYYDKHFTEFVPLRTKAKEILQEEE
DLAEIVQLVGKASLAETDKITLEVAKLIKDDFLQQNGYTPYDRFCPFYKTVGMLS
NMISFYDMARRAVETTAQSDNKITWSIIREHMGEILYKLSSMKFKDPVKDGEAKI
KADYAQLLEDMQNAFRSLED
C  
    
    
    
    
    
    
    
 D    
FIGURE 1
V-ATPase A subunit Sequence Alignment
Danio rerio (zebrafish) 160 SLIKHKLMLPPRSRGTVTYVAPPGNYDVSDV  190
Xenopus laevis (frog) 160  SLIRHKLMLPPRNRGTVTYVAPPGHYDTSDV  190
Rattus norvegicus (rat) 160  SLIKHKIMLPPRSRGSVTYIAPPGNYDASDV  190
Mus musculus (mouse) 160  SLIKHKIMLPPRNRGSVTYIAPPGNYDASDV  190
Homo sapiens (human) 160  SLIKHKIMLPPRNRGTVTYIAPPGNYDTSDV  190
Danio rerio (zebrafish) 160 SLIKHKLMLPPRSRGTVTYVAPPGNYDVSDV  190
Xenopus laevis (frog) 160  SLIRHKLMLPPRNRGTVTYVAPPGHYDTSDV  190
Rattus norvegicus (rat) 160  SLIKHKIMLPPRSRGSVTYIAPPGNYDASDV  190
Mus musculus (mouse) 160  SLIKHKIMLPPRNRGSVTYIAPPGNYDASDV  190
Homo sapiens (human) 160  SLIKHKIMLPPRNRGTVTYIAPPGNYDTSDV  190
*
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